Home

Home

article image

Closing in on the brain

The new Nextim system, eXimia NBS is a novel brain stimulation technology which provides individual measures of the health and functional capacity of the central nervous system, as well as of brain reactions to targeted magnetic pulses. Thanks to its advanced technology and proven clinical performance, the NBS system helps medical professionals to focus on the issues that matter the most – and to find the shortest way to the core of non-invasive brain stimulation.

The eXimia NBS aligns the MR images with the subject’s head real-time – targeting and timing the transcranial magnetic stimulation (TMS) pulses accurately. The direct muscle and brain responses (EMG and EEG) evoked by TMS stimulus can be recorded with high temporal resolution. The eXimia NBS system is fully compatible with Nexstim, Medtronic and Magstim TMS stimulators. As the activation of stimulated neuronal structures is instantly visible, the effects of the stimulus can be quickly determined. Since the eXimia NBS system also predicts and monitors the stimulus location and dose within the brain, it can detect and identify minor alterations in neuronal functioning.
In clinical work, the eXimia NBS Navigation system helps neurologists and neurosurgeons to diagnose and treat human brain diseases, trauma, and dysfunctions earlier and more accurately than before. NBS is not limited to structural alternatives – instead, it opens a new window to the functions of the human brain. The eXimia NBS provides solid platforms for new, advanced studies of the central nervous system.

This article was published on 11/14/2006

Search

 

Service

Company News

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Meet us at MEDICA! Hall 7 Stand 15

The European Hospital team will be happy to hear about your research, products, R&D or trials and launches, hospital management issues, or any other aspects of your work, so that we can discuss your editorial ideas. We will also be pleased to help with any PR or advertising queries.

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.